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Abstract
Background: Nosocomial infections pose substantial risk to patients receiving care in hospitals. In Africa, this
problem is aggravated by inadequate infection control due to poor hygiene, resource and structural constraints,
deficient surveillance data and lack of awareness regarding nosocomial infections. We carried out this study to
determine the incidence and spectrum of nosocomial infections, pathogens and antibiotic resistance patterns in a
tertiary regional hospital in Lambaréné, Gabon.
Methods: This prospective case study was carried out over a period of six months at the Albert Schweitzer
Hospital, Lambaréné, Gabon. All patients admitted to the departments of surgery, gynecology/obstetrics and
internal medicine were screened daily for signs and symptoms of hospital-acquired infections.
Results: A total of 2925 patients were screened out of which 46 nosocomial infections (1.6%) were diagnosed.
These comprised 20 (44%) surgical-site infections, 12 (26%) urinary-tract infections, 9 (20%) bacteraemias and 5
(11%) other infections. High rates of nosocomial infections were found after hysterectomies (12%) and Caesarean
sections (6%). Most frequent pathogens were Staphylococcus aureus and Escherichia coli. Eight (40%) of 20 identified
E. coli and Klebsiella spp. strains were ESBL-producing organisms.
Conclusion: The cumulative incidence of nosocomial infections in this study was low; however, the high rates
of surgical site infections and multi-resistant pathogens necessitate urgent comprehensive interventions of
infection control.
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Background
Health-care-associated infection (HAI), otherwise known
as nosocomial infection, is a major global safety concern
for both patients and health-care professionals [1-3].
Excess morbidity, mortality and costs of illnesses caused
by nosocomial infections have been demonstrated by
several studies [1-7]. In the developed countries, it has
been reported to affect from 5% to 15% of hospitalized
patients in regular wards and as many as 50% or more of
patients in intensive care units (ICUs), while in developing
countries the magnitude of the problem remains largely
underestimated [3,8]. Only few studies have focused on
nosocomial infections in developing countries, especially
in Sub-Saharan Africa [9,10]. As shown in a recent meta-
analysis of 220 studies from developing countries (of
which only 14 studies were from Africa) high rates of
nosocomial infections with an incidence of 7.4 infections
per 100 patients were found [10].
Urinary-tract infections represent the most frequent
form of nosocomial infections in industrialized nations,
while in developing countries invasive medical procedures
play a major role [1,11,12]. Surgical interventions are one
of the biggest sources of nosocomial infections with an
incidence ranging from 1.2% to 23.6% of all surgical
interventions and Staphylococcus aureus (20%), Escherichia
coli (18%) and other Enterobacteria constituting the most
frequent causative pathogens in developing countries
[10,13-15]. Apart from patient-related factors (e.g. co-
infection of other local sites, malnutrition and/or immune-
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deficiency), the quality of equipment, financial resources
as well as the competence of the surgical team seem to be
important determinants [13].
In developing countries a growing proportion of noso-
comial infections can be assigned to methicillin-resistant
S. aureus (MRSA) and multi-resistant Gram-negative bac-
teria [12,14]. In a recent study in Tanzania [15], surgical
site infection (SSI) was detected in 65 (26.0%) patients, of
whom 56 (86.2%) and 9 (13.8%) had superficial and deep
SSI respectively. Among 65 patients with clinical SSI,
56(86.2%) had positive aerobic culture. S. aureus was
the predominant organism 16/56 (28.6%); of which 3/
16 (18.8%) were MRSA. This was followed by Escherichia
coli 14/56 (25%) and Klebsiella pneumoniae 10/56 (17.9%).
Among the E. coli and K. pneumoniae isolates 9(64.3%)
and 8(80%) were ESBL producers respectively. In Niger,
a study reported up to 31% ESBL colonization rates on
hospital admission [16].
The rapid spread of antibiotic-resistance poses an im-
mense threat to health systems of these countries where
adequate antibiotic treatment of infectious diseases is often
hampered by financial constraints [17-19]. For Gabon and
most of Central Africa, data on nosocomial infections are
lacking; hence this study was carried out to estimate the
incidence of hospital-acquired infections and characterise
the pathogens responsible at a rural hospital in Central
Africa as a first step to reduce nosocomial infections.
Methods
Study area
Lambaréné has approximately 24000 inhabitants and lies
on the Ogooué River, in a region predominantly covered
by dense tropical rain forest in Central Africa. The Albert
Schweitzer Hospital, a 150 bed health facility, has a catch-
ment population of about 50000 persons and provides
surgical, internal medical, obstetrics/gynecological and
pediatric services.
Study procedures
We undertook a prospective surveillance study in order
to determine the incidence of nosocomial infections at
the Albert Schweitzer Hospital. The study was carried
out in the departments of aseptic surgery (clean and
clean contaminated surgery), septic surgery (contaminated
surgery), gynecology/obstetrics and internal medicine with
a total of 114 beds. The study lasted six months from
January to July 2009. On daily rounds all patients were
screened daily for signs and symptoms of nosocomial
infections. Patients with a new occurrence of fever (> 38°C)
at least 48 hours after admission or a repeated episode
of fever after a non-febrile interval of 72 hours, signs of
infection at the site of surgical operations, or a reopening
of the operation site due to infection qualified for fur-
ther evaluation. Further evaluation consisted of a clinical
examination, and personal data, reason for hospitalization,
operations, current signs and symptoms, and inserted
venous or urinary catheters were recorded. Days from
admission to occurrence of fever or other signs and
symptoms of nosocomial infections were noted.
Based on clinical signs and symptoms, specific labora-
tory tests were performed. For every patient with fever
(> 38°C), blood and urine cultures as well as parasito-
logical examination of thick blood smear for exclusion of
malaria were carried out. In case of a suspected surgical
site infection a wound swab was obtained and processed
in the microbiology laboratory. Specific symptoms like
diarrhoea or abnormal breathing sounds led to stool
examinations or chest x-ray, respectively. To ensure that
an additional nosocomial infection of the same patient
had originated independently from a previous one, the
patient had to be symptom free for at least 72 hours or
the infection had to affect a different localisation or
grow a different pathogen. Classification of cases occurred
according to the definitions of nosocomial infections of
the Robert Koch Institute (RKI) in Berlin which were
based on the current CDC guidelines [20]. These criteria
give an epidemiological definition of nosocomial infections
to be able to compare surveillance data from different
studies. The time for occurrence of nosocomial infection
was noted and analysed; and patients who had no nosoco-
mial infection at the time of initial screening were
followed up daily for symptoms of nosocomial infections
until they were discharged. Patients with nosocomial
infections were also followed up until discharge.
Laboratory procedures
Microbiological specimens were processed according to
good laboratory practice and standard methods for iden-
tification. Briefly, blood cultures were collected in Bactec
blood culture bottles (BD Blood Culture System, Becton,
Dickinson and Company) and incubated at 37°C in Bactec
9050. Positive bottles were subcultured on blood, choc-
olate and MacConkey agar. Swabs and urine were plated
on blood and MacConkey agar. Bacteria were identified
by tube coagulase and latex tests for staphylococci, latex
test for streptococci, pyrase testing for enterococci and
API-20E and API-20NE (Biomeriux) for enterobacteriaceae
and non-fermenting Gram-negative rods respectively. Sus-
ceptibility to antibiotics was tested using the microdilution
method according to CLSI guidelines [21] Inducible clinda-
mycin resistance is not routinely tested in our laboratory
and therefore not reported. Antibiotics tested were chosen
according to local availability and included penicillin,
oxacillin, ampicillin, amoxicillin/clavulanic acid, ceftriaxon,
gentamicin, ciprofloxacin, co-trimoxazole, clindamycin,
chloramphenicol and erythromycin. Extended Spectrum
β-Lactamase (ESBL) production was confirmed by disc
diffusion test. The production of extended-spectrum
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beta-lactamase was confirmed in all ceftriaxone resistant
Enterobacteriaceae using the double-disks method accord-
ing to the manufacturer’s instruction (Mast discs, Mast
diagnostics, Merseyside, UK). This test applies discs of
three different beta-lactam antibiotics (ceftazidim 30 μg,
cefotaxime 30 μg, cefpodoxime 10 μg) with and without
clavulanic acid. Methicillin-resistance was confirmed
for all cefoxitin-resistant Staphylococcus aureus using a
PBP2a-agglutination test (PBP2’ Test Kit, Oxoid, Japan).
Data analysis
Data collected from patients with signs and symptoms
of nosocomial infections (age, sex, length of hospital stay,
type of nosocomial infection, days to first clinical sign
or symptom of nosocomial infection, type of operation
if applicable) were entered in a Microsoft® Access 2002
data bank. Data on all hospitalised patients was available
for either individual patients (sex, age) or aggregated over
a month (mean duration of stay). For statisical analysis,
IBM SPSS® Statistics (version 19) was used. The continu-
ous variables were expressed as median (25-75% quantiles)
and compared between groups using the Mann–Whitney
U test. Categorical variables were expressed in percentage
(proportion). Statistical analysis was supervised by a statis-
tician at the Institute of Medical Biometrics and Medical
Informatics for Biometrics, Albert’s Ludwig University of
Freiburg, Germany.
Ethics
The study was approved by the Regional Ethical Com-
mittee, “Comité d’Ethique Régional Independent de
Lambaréné (CERIL)”. Written informed consent was
obtained from all patients’ prior inclusion into the
study.
Results
During the six months period of this study, 2925 pa-
tients were admitted to the participating wards of the
Albert Schweitzer Hospital. The mean duration of stay
was 4.4 days resulting in 12870 hospital days.
The median age was 30 (22–42) years, 65% of all patients
were female and 35% were male. In total, 84 patients met
our criteria for further evaluation for suspected nosocomial
infections and 46 nosocomial infections were confirmed
in 36 patients out of 2925 inpatients. A single nosocomial
infection was diagnosed in 30 patients, two infections were
found in three patients, three infections in two patients,
and four infections in one patient. Forty eight patients
who were further evaluated did not have a nosocomial
infection as defined by the epidemiological criteria of
the RKI. Forty (87%) episodes of nosocomial infections
were confirmed by microbiological examinations, while
the remaining six infections were diagnosed on clinical
grounds only. During the study four (11%) of the patients
with nosocomial infections died.
The cumulative incidence of nosocomial infections was
1.6 infections per 100 patients in six months (95% CI
1.1 - 2.0) or 3.6 infections per 1000 in-patient days
(95% CI 2.6 – 4.6). Details about the incidence of nosoco-
mial infections at the respective departments are shown in
Table 1. With a total of 20 cases (44%) surgical-site infec-
tions were the most frequent type of hospital-acquired
infection, followed by twelve (26%) urinary-tract infections
(of which 4 were catheter related infections), nine (20%)
bloodstream infections and five (11%) other infections (e.g.
diarrhoea, phlebitis, decubitus ulcer infection).
During the study period, a total of 1059 surgical opera-
tions on 992 patients were performed. The finding of 20
surgical-site infections corresponded to an overall infection
rate of 1.9% (95% CI 1.1 - 2.7%) per operation. In Table 2,
the number and incidence of nosocomial infections per
type of surgical operation are shown for the most fre-
quently performed aseptic operations. Abdominal hys-
terectomies had the highest incidence of nosocomial
infections with 11.5% (95% CI 0.0 - 23.8).
Patients with nosocomial infections had a median age
of 41 (33–69)years, which is significantly higher than the
age of patients who did not acquire infections during
hospitalisation 30 (22–41) years, p <0.001). Regarding
the incidence of nosocomial infections, no significant
difference in sex was found (p = 0.08). The duration of
in-patient care of patients with nosocomial infections
ranged from four to 108 days with a median of 22 (13–
34) days. The first clinical signs of nosocomial infection
appeared after a median of 6 (4–10) days of patient care.
Approximately half (24/46) of all nosocomial infections
developed under antibiotic treatment.
In total, 68 blood cultures, 67 urine cultures and 52
wound swabs were sent for microbiological evaluation.
As shown in Table 3, 36 Gram-positive and 34 Gram-
negative bacteria were identified in 40 specimens. The
most frequent pathogen was S. aureus, in most cases ori-
ginating from surgical-site infections, followed by E. coli
as a cause of nosocomial urinary-tract infections and
Enterococcus spp. from surgical-site infections. K. pneu-
moniae was identified from urinary-tract and bloodstream
infections, while anaerobes were exclusively found in
specimen from surgical sites.
The antibiotic susceptibility profiles of the nosocomial
pathogens are detailed in Table 3. A total of eight multi-
resistant strains of Gram-negative bacteria with ESBL-
production were detected, comprising five E. coli and
three K. pneumoniae strains. Four of the ESBL-producing
bacteria were resistant to the whole spectrum of antibi-
otics available at the Albert Schweitzer hospital. Six ESBL-
positive bacteria caused nosocomial infections while the
patients were on continued perioperative prophylactic
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Surgery 31/1022 3.0% (2.0 – 4.1) 5.1 (3.3 - 6.9) 1.4 (0.7 - 2.1) 2.3 (1.1 – 3.5) 1.1 (0.5 - 1.7) 1.8 (0.8 – 2.8) 0.2 (0.0 - 0.5) 0.3 (0 – 0.7)
Aseptic1) surgery 20/689 2.9% (1.6 – 4.2) 8.6 (4.9 - 12.3) 1.9 (0.8 - 2.9) 5.6 (2.6 – 8.5) 0.7 (0.1 - 1.4) 2.1 (0.2 – 4.1) 0.1 (0–0.4) 0.4 (0 – 1.2)
Septic2) surgery 11/333 3.3% (1.4 - 5.2) 2.9 (1.2 - 4.7) 0.3 (0–0.9) 0.3 (0 – 0.8) 1.8 (0.4 - 3.2) 1.6 (0.2 – 3.0) 0.3 (0–1.9) 0.3 (0 – 0.9)
Gynaecology 12/1047 1.1% (0.5 - 1.8) 4.0 (1.8 - 6.1) 0.6 (0.1 - 1.0) 2.0 (0.4 – 3.6) 0.1 (0.0 - 0.3) 0.3 (0 – 0.9) 0.5 (0.1 - 0.9) 1.7 (0.3 – 3.0)
Internal medicine 3/856 0.4% (0.0 - 0.7) 0.8 (0–1.8) 0 (−) 0 (−) 0 (−) 0 (−) 0.2 (0.0 - 0.5) 0.5 (0 – 1.3)
All departments 46/2925 1.6% (1.1 - 2.0) 3.6 (2.6 - 4.6) 0.7 (0.4 - 1.0) 1.6 (1.0 – 2.1) 0.4 (0.2 - 0.6) 0.9 (0.4 – 1.5) 0.3 (0.1 - 0.5) 0.7 (0.3 – 1.1)
1)Clean and clean-contaminated surgery.



















antibiotic treatment with an aminopenicillin w/o ß-lacta-
mase inhibitor or ceftriaxon.
Discussion and conclusions
In many developing countries particularly in sub-Saharan
Africa, data about the incidence of hospital-acquired infec-
tions at rural hospitals are lacking, as modern microbio-
logical laboratories are generally restricted to hospitals in
major cities. Between January and July 2009 we performed
daily ward rounds in the departments of surgery, internal
medicine and obstetrics/gynecology to document all noso-
comial infections as defined by the CDC criteria. The over-
all rate of nosocomial infections at the Albert Schweitzer
hospital excluding the pediatric department was 46 cases in
12870 hospital days corresponding to an incidence density
of 3.6 per 1000 in-patient days. With nearly 44% of all
cases, surgical-site infections were the most frequently
diagnosed nosocomial infections, followed by urinary-tract
infections (26%), bloodstream infections (20%) and other
infections (11%). This is in agreement with findings in
other studies from developing countries where surgical-
site infections made up the majority of hospital-acquired
infections [1,9,14,15]. The missing evidence of nosocomial
respiratory tract infections as defined by the CDC criteria
during the study period could be explained by the absence
of an intensive-care unit with invasive ventilation proce-
dures [22,23] and the restricted availability of the X-ray
machine.
We found a very low overall nosocomial infection inci-
dence rate as compared with the average incidence of
nosocomial infections in developing countries of 7.4%
[8,14,15]. Possible reasons for this could be the small
size of the hospital (114 beds) and the on-average short
duration of in-patient stay (mean 4.4 days). The absence
of an intensive care unit, the limited spectrum of opera-
tions and the fact that certain invasive procedures like
insertion of central venous catheters were not performed
could also have contributed to a comparatively low in-
cidence of hospital-acquired infections at the Albert
Schweitzer hospital. On the other hand it could also be
due to a high level of awareness of the need for aseptic
procedures among doctors and nurses at our hospital.
The finding of 20 surgical-site infections corresponded
to an infection rate of 1.9 (95% CI 1.1 - 2.7%) per 100
surgical procedures. This was also lower than the pooled
cumulative incidence of 5.6% reported from other devel-
oping countries [10] or 26% reported from Tanzania [15].
But the infection rates for specific surgical operations such
as caesarean sections (6.3%) and hysterectomies (11.5%)
clearly were above the rates reported from American
surveillance studies (1.5% - 3.8% for caesarean sections
and 1.1% - 4.1% for hysterectomies) [24]. The low overall
rate was probably due to the fact that most operations
performed at the Albert Schweitzer hospital were low
risk procedures and surgical procedures with a high
risk of nosocomial infection as found in Tanzania (open
prostatectomy, mastectomy, spina bifida repair) [15]
were not done. This emphasizes the fact that for meaning-
ful comparisons of nosocomial infection risks, hospitals
with similar patient characteristics and invasive proce-
dures have to be compared.
While the most frequent pathogens of nosocomial infec-
tions at the Albert Schweitzer hospital were similar to data
from other countries, the resistance patterns of certain
strains of bacteria were alarming. The finding that E. coli, as
the second-most isolated pathogen in Lambaréné, was sen-
sitive to ampicillin in only one of 14 cases (i.e. 7%, 95% CI
0 – 21%) and that sensitivity to broad spectrum antibiotics
such as ceftriaxone, ciprofloxacin and gentamicin was
found in only nine out of 14 cases (95% CI 39 - 89%) is
of particular concern. Similarly worrisome is the reduced
sensitivity of K. pneumoniae strains, of which only half were
sensitive to ceftriaxone, ciprofloxacin and gentamicin.
These alarming resistance rates may reflect the high use of
antibiotics either in hospital or as outpatients in a country
where antibiotics are freely available over the counter.
One of our most striking findings was the fact that five
of 14 E. coli strains (36%) and three of six K. pneumoniae
strains (50%) were ESBL-producers. Similar resistance
rates have been described in screening isolates and clinical
isolates in Tanzania (15), Ghana [25], Cameroon [26] and
Sudan [27], Four of the ESBL-producing bacteria were
resistant to the whole spectrum of antibiotics available
at the Albert Schweitzer hospital. While colonisation
with MRSA was identified in two patients, MRSA caus-
ing nosocomial infections was not found. This observed
high rate of antibiotic resistance among our isolates is
in agreement with a review of published literature on
bacteria resistance in Central Africa (1955–2008) showing
that the Central African region shares the worldwide trend
of increasing antimicrobial resistance [28,29]. There is an
urgent need of sound surveillance based on competent
and affordable microbiology to provide clear and fairly fre-
quent data on antimicrobial resistance.








Abdominal hysterectomy 3/26 11.5 (0.0 - 23.8)
Caesarean section 5/80 6.3 (0.9 - 11.6)
Appendectomy 1/17 5.9 (0.0 - 17.1)
Myomectomy 1/19 5.3 (0.0 - 15.3)
Salpingectomy
(ectopic pregnancy)
1/22 4.5 (0.0 - 13.2)
Herniotomy 2/124 1.6 (0.0 - 3.8)
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Antibiotics (No. of sensitive pathogen/no. of tested pathogens)
Penicillin Cloxacillin Ampicillin Amoxicillin +
Clavulanic acid
Ceftriaxone Gentamicin Ciprofloxacin Cotrimoxazole
Staphylococcus
aureus
15 (21.4%) 9 0 5 *0/14 14/14
Escherichia coli 14 (20.0%) 3 8 1 - - 1/14 6/14 9/14 9/14 9/14 3/12*
Enterococcus 9 (12.9%) 5 4 0 0/9 - 9/9 - - - - -
Klebsiella
pneumoniae
6 (8.6%) 0 3 3 - - 0/6 2/6 3/6 3/6 3/6 1/5*
Anaerobes 6 (8.6%) 6 0 0 - - - - - - - -
Acinetobacter
species
4 (5.7%) 1 3 0 - - 0/4 1/4 0/4 2/4 3/4 1/4
Streptococcus
pyogenes
3 (4.3%) 2 0 1 3/3 - 3/3 - - - - -
Other bacteria# 13 (18.6%) 11 2 0 - - - - - - - -
*Antibiotic resistance testing was not performed for some pathogens.



















More than half of all nosocomial bacterial infections
acquired in the Albert Schweitzer hospital were diagnosed
in patients under antibiotic medication. Similar observa-
tions have been reported from other African countries,
like Ethiopia, where 72% of nosocomial infections devel-
oped under antibiotic prophylaxis [30]. In the present
study six of eight cases of nosocomial infections with
ESBL-producing bacteria occurred while the patients were
on prophylactic or therapeutic antibiotic therapy already.
These findings support the view that inappropriate use of
anti-infectious medications including routine antibiotic
prophylaxis of long duration is a major factor favouring
infection with multi-resistant pathogens [16-19,25-28].
With a mean stay of 27 (range: 4–108) days, patients
with nosocomial infections stayed in hospital for 23 days
longer than the average patient. This may partly be
explained by the hypothesis that patients developing
nosocomial infections have more co-morbidities which
lead to longer inpatient care per se and therefore exposes
them to the risk of hospital-acquired infections for a lon-
ger time period. This hypothesis is supported by the fact
that initial clinical manifestations of nosocomial infections
were observed on median day 8 of hospitalization which is
twice the average duration of stay of all patients. At the
same time nosocomial infections also have been reported
to lead to prolonged hospital stay [31].
There are several limitations to this study. Hospital -ac-
quired infections that arose after discharge were not
detected due to lack of follow-up. Because a temp-
erature >38°C was the main inclusion criterion except
for patients with a surgical site infection we might have
underestimated the rate of nosocomial infections in
patients receiving antipyretics.
The results of this study revealed that nosocomial in-
fections represent a substantial threat for patients at the
Albert Schweitzer hospital. Although the overall incidence
rate of nosocomial infections was lower than in hospitals
from other developing countries we found several areas
for improvement. At the Albert Schweitzer hospital, a
particular high risk of nosocomial infections was found
after gynecological operations. Thus, interventions to
decrease hospital-acquired infections by e.g. infection
control or appropriate perioperative prophylaxis should
start here. This study also showed that hospital wide
nosocomial infection rates have to be interpreted care-
fully because they depend on the services offered at the
respective hospital and on patient characteristics.
Many of the identified pathogens, particularly the
Gram-negative bacteria have developed resistance to
commonly prescribed antibiotics. Moreover, against ESBL-
strains identified in this study no effective antibiotics were
available at the Albert Schweitzer hospital. This means
antibiotics to deal with infections with multiresistant
bacteria have to be made available and in the long run
interventions to reduce the rate of multiresistant pathogens
have to be taken. These could, for example, consist of intro-
ducing antibiotic stewardship measures which includes ap-
propriate use of antibiotic medications in the hospital
setting [28]. These strategies can only be accomplished by
quality management involving different disciplines, and
capacity building of the personnel. We also showed that at
small rural hospitals detailed surveillance of nosocomial in-
fections is mandatory to be able to reduce hospital-
acquired infections and improve patient outcome.
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